Literature DB >> 22337570

Diverse sensory inputs permit priming in the acidic saline model of hyperalgesia.

L L Jasper1, B J MacNeil.   

Abstract

BACKGROUND: The rodent acidic saline model of hyperalgesia uses repeat injections of acidic saline in the right lateral gastrocnemius muscle, spaced five days apart, to induce a persistent decrease in hindpaw withdrawal thresholds. The objective of this study was to determine if alternate injection sites would permit development of hyperalgesia.
METHODS: The location of the first muscle injection was varied between 3 groups of rats to include the right lateral gastrocnemius, the right medial gastrocnemius or the left lateral gastrocnemius. All second injections were placed in the right lateral gastrocnemius.
RESULTS: As reported by others, placing both injections in the right lateral gastrocnemius produced a significant reduction in paw withdrawal thresholds 24 hours after the second injection (p < 0.05). Relocating the first injection to the right medial gastrocnemius or the left lateral gastrocnemius also produced significant reductions in paw withdrawal thresholds (p < 0.05 for both). Hyperalgesia was also observed if the first muscle injection was replaced with a systemic injection of lipopolysaccharide. Further experiments tested whether glia cells may contribute to the priming process. Pretreatment with minocycline prior to the first injection completely blocked the development of hyperalgesia but was ineffective if injected before the second injection.
CONCLUSIONS: These data indicate that anatomically diverse peripheral stimuli can converge within the central nervous system to produce hyperalgesia.
© 2012 European Federation of International Association for the Study of Pain Chapters.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22337570      PMCID: PMC3357443          DOI: 10.1002/j.1532-2149.2011.00103.x

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  35 in total

1.  Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia.

Authors:  Xiao-Ying Hua; Camilla I Svensson; Tomohiro Matsui; Bethany Fitzsimmons; Tony L Yaksh; Michael Webb
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

2.  Excitatory amino acid concentrations increase in the spinal cord dorsal horn after repeated intramuscular injection of acidic saline.

Authors:  D A Skyba; T L Lisi; K A Sluka
Journal:  Pain       Date:  2005-11-16       Impact factor: 6.961

3.  Spinal cord glia and interleukin-1 do not appear to mediate persistent allodynia induced by intramuscular acidic saline in rats.

Authors:  Annemarie Ledeboer; John H Mahoney; Erin D Milligan; David Martin; Steven F Maier; Linda R Watkins
Journal:  J Pain       Date:  2006-10       Impact factor: 5.820

4.  Microglial reactions after subcutaneous formalin injection into the rat hind paw.

Authors:  K Y Fu; A R Light; G K Matsushima; W Maixner
Journal:  Brain Res       Date:  1999-04-17       Impact factor: 3.252

5.  Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat.

Authors:  S M Sweitzer; R W Colburn; M Rutkowski; J A DeLeo
Journal:  Brain Res       Date:  1999-05-22       Impact factor: 3.252

6.  Systemic administration of minocycline inhibits formalin-induced inflammatory pain in rat.

Authors:  Ik-Hyun Cho; Young Min Chung; Chul-Kyu Park; Seong-Hae Park; Haeyeong Lee; Hai Ying Li; Donghoon Kim; Zheng Gen Piao; Se-Young Choi; Sung Joong Lee; Kyungpyo Park; Joong Soo Kim; Sung Jun Jung; Seog Bae Oh
Journal:  Brain Res       Date:  2006-01-19       Impact factor: 3.252

7.  The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1beta responses to stress.

Authors:  Peter Blandino; Christopher J Barnum; Terrence Deak
Journal:  J Neuroimmunol       Date:  2006-01-04       Impact factor: 3.478

8.  Neurocircuitry of illness-induced hyperalgesia.

Authors:  L R Watkins; E P Wiertelak; L E Goehler; K Mooney-Heiberger; J Martinez; L Furness; K P Smith; S F Maier
Journal:  Brain Res       Date:  1994-03-14       Impact factor: 3.252

9.  Differential induction of c-Fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin.

Authors:  W Wan; L Janz; C Y Vriend; C M Sorensen; A H Greenberg; D M Nance
Journal:  Brain Res Bull       Date:  1993       Impact factor: 4.077

10.  Descending facilitatory pathways from the RVM initiate and maintain bilateral hyperalgesia after muscle insult.

Authors:  D V Tillu; G F Gebhart; K A Sluka
Journal:  Pain       Date:  2007-08-30       Impact factor: 7.926

View more
  5 in total

1.  Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism.

Authors:  Ji-Young V Kim; Dipti V Tillu; Tammie L Quinn; Galo L Mejia; Adia Shy; Marina N K Asiedu; Elaine Murad; Alan P Schumann; Stacie K Totsch; Robert E Sorge; Patrick W Mantyh; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

2.  Long-lasting reflexive and nonreflexive pain responses in two mouse models of fibromyalgia-like condition.

Authors:  Beltrán Álvarez-Pérez; Meritxell Deulofeu; Judit Homs; Manuel Merlos; José Miguel Vela; Enrique Verdú; Pere Boadas-Vaello
Journal:  Sci Rep       Date:  2022-06-12       Impact factor: 4.996

3.  Sleep fragmentation exacerbates mechanical hypersensitivity and alters subsequent sleep-wake behavior in a mouse model of musculoskeletal sensitization.

Authors:  Blair C Sutton; Mark R Opp
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

4.  Resident Macrophages in Muscle Contribute to Development of Hyperalgesia in a Mouse Model of Noninflammatory Muscle Pain.

Authors:  Wei-Yi Gong; Ramy E Abdelhamid; Carolina S Carvalho; Kathleen A Sluka
Journal:  J Pain       Date:  2016-07-01       Impact factor: 5.820

Review 5.  Animal models of fibromyalgia.

Authors:  Josimari M DeSantana; Kamilla M L da Cruz; Kathleen A Sluka
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.